Ozempic Receives FDA Approval To Treat Kidney Disease
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...
How to Play NVO Stock After New Drug's Success in Obesity Study
The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...
Hosted on MSN2d
Singer claims she's been left with bone-thinning disease after taking Ozempic
The use of weight-loss injections has become near-normalised in today's society, but one singer is joining the charge in warning against their side effects, after she claims Ozempic has left her with ...
Bitcoin drops below $100,000 in risk-off move as Nasdaq stocks are hit
Crypto is in a cooling period after running to a new record last week and was pulled lower by the DeepSeek-driven sell-off in tech stocks.
Investors betting on the Trump trade may be missing some real risks
Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.
San Francisco may be seeing a political shift and it could be starting in Chinatown
Huge crowds have come out to Chinatown for Lunar New Year as new political faces take office. She made the look her own with ...
Lizzo Says She’s Reached Her ‘Weight Release Goal’: See Her Latest Photos
Lizzo ‘s feeling “Good as Hell” about herself after reaching her weight loss goals — or “weight release” goals, as she gently ...
Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin
Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...